Global Migraine Market Analysis, Trends & Outlook to 2022

Migraine headache is typically throbbing, unilateral (one sided), and is aggravated by physical activity. It typically presents with additional symptoms in addition to headache pain, including nausea, and sensitivity to light and/or sound.

Depending on symptoms, migraine is broadly classified into two categories, Chronic and Episodic. Migraines can be treated with two types of drugs: pain-relieving and preventive. Pain-relieving medications are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. Preventive treatment is considered if migraine occurs frequently, typically more than one migraine per week, or if migraine symptoms are severe.

The global migraine market is expected to grow in future due to increasing female population, rising health expenditure, accelerating economic growth, increasing cigarette consumption, rising prevalence of migraine and unmet needs. Key trends of this market include development of migraine drugs and growing awareness regarding migraine and its treatments. However, there are some factors which can hinder the growth of migraine market which includes regulatory challenges, high cost, adverse effects of drugs, lack of proper diagnosis and increased preference of alternative therapies.

The report “Global Migraine Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, with focus majorly on the U.S. market. The report profiles the key players of the market including Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals.

Browse Full Report with TOC- https://www.marketresearchhub.com/report/global-migraine-market-industry-analysis-outlook-20182022-report.html

Table of Content

1. Overview
1.1 Introduction
1.2 Types
1.3 Stages
1.4 Diagnosis
1.5 Treatment

2. Global Market Analysis
2.1 Global Migraine Market by Value
2.2 Global Migraine Market Forecast by Value
2.3 Global Migraine Market by Drug Type
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
2.5 Global Therapeutic Botulinum Toxin Market by Indication

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Migraine Population Forecast
3.1.2 The U.S. Diagnosed & Treated Adult Migraine Population
3.1.3 The U.S. Migraine Population with CV Risk Factors
3.1.4 The U.S. Migraine Treatment by Specialty
3.1.5 The U.S. Migraine Treated Population by Drug Type
3.1.6 The U.S. Acute Migraine Prescription Volume
3.1.7 The U.S. Migraine Prophylaxis Market by Treatment
3.2 The U.S. Migraine Drugs Revenue
3.2.1 The U.S. Botox Migraine Revenue and Treated Patients
3.2.2 The U.S. Cambia Drug Revenue
3.2.3 The U.S. Lasmiditan Drug Revenue & Treated Patients
3.2.4 The U.S. Alder Drug Revenue
3.2.5 The U.S. Erenumab Drug Revenue and Treated Patients
3.2.6 The U.S. Galcanezumab Drug Revenue and Treated Patients
3.2.7 The U.S. Fremanezumab Drug Revenue and Treated Patients
3.3 Europe
3.3.1 Europe Total Migraine and Diagnosed Population
….

Enquire about this Report- https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1803601